“PHARMACOLOGIC TOPOISOMERASE-I INHIBITION CAUSES DNA DAMAGE AND MORTALITY IN ACTIVATED CD4+ T CELLS” (2018) Genetics & Applications, 2(2), pp. 51–56. doi:10.31383/ga.vol2iss2pp51-56.